Total Payments
$3,818
2024 Payments
$187.06
Companies
19
Transactions
41
Medicare Patients
2,180
Medicare Billing
$141,498
Payment Breakdown by Category
Education$3,000 (78.6%)
Food & Beverage$817.75 (21.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,000 | 1 | 78.6% |
| Food and Beverage | $817.75 | 40 | 21.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,000 | 1 | $0 (2019) |
| ABBVIE INC. | $127.38 | 7 | $0 (2024) |
| PFIZER INC. | $113.62 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $96.26 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $69.67 | 5 | $0 (2019) |
| 180 Medical, Inc. | $64.53 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $62.08 | 3 | $0 (2023) |
| Antares Pharma, Inc. | $55.37 | 3 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $55.26 | 2 | $0 (2023) |
| Tolmar, Inc. | $27.79 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.06 | 9 | Merck Sharp & Dohme LLC ($62.30) |
| 2023 | $259.89 | 12 | Sumitomo Pharma America, Inc. ($55.26) |
| 2022 | $87.58 | 5 | Antares Pharma, Inc. ($37.08) |
| 2021 | $20.26 | 1 | AbbVie Inc. ($20.26) |
| 2019 | $3,126 | 5 | Intuitive Surgical, Inc. ($3,000) |
| 2018 | $137.34 | 9 | Astellas Pharma US Inc ($44.74) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/22/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: ONCOLOGY | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 03/20/2024 | 180 Medical, Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: CONTINENCE CARE | ||||||
| 03/19/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/20/2023 | 180 Medical, Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: CONTINENCE CARE | ||||||
| 11/13/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2023 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Urology | ||||||
| 10/05/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| 10/03/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: HORMONE THERAPY | ||||||
| 06/26/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Oncology | ||||||
| 04/20/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/10/2023 | Cook Medical LLC | RESONANCE (Device) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: Urology | ||||||
| 02/21/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: rezum_URO | ||||||
| 02/16/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: HORMONE THERAPY | ||||||
| 01/11/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/22/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Continence Care | ||||||
| 10/27/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 09/19/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 597 | 688 | $106,673 | $39,911 |
| 2022 | 7 | 472 | 584 | $92,396 | $35,078 |
| 2021 | 14 | 638 | 806 | $115,037 | $44,130 |
| 2020 | 9 | 473 | 560 | $68,454 | $22,379 |
Total Patients
2,180
Total Services
2,638
Medicare Billing
$141,498
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 77 | $41,272 | $12,303 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 199 | $22,288 | $11,463 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 41 | $6,765 | $3,361 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,765 | $3,355 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $6,513 | $2,609 | 40.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $6,846 | $2,468 | 36.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,346 | $1,391 | 41.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $3,111 | $1,084 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 23 | $1,725 | $857.87 | 49.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 138 | 162 | $2,268 | $542.19 | 23.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 41 | 45 | $2,025 | $295.64 | 14.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 14 | $644.00 | $148.40 | 23.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 15 | 15 | $105.00 | $32.55 | 31.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 81 | 97 | $51,992 | $16,211 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 184 | $20,608 | $10,489 | 50.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $7,849 | $3,733 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 33 | $5,445 | $2,758 | 50.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 30 | $2,250 | $1,062 | 47.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 117 | 143 | $2,002 | $493.23 | 24.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 39 | 50 | $2,250 | $332.08 | 14.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 65 | 81 | $43,416 | $13,014 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 158 | 208 | $23,296 | $12,418 | 53.3% |
| 52234 | Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope | Facility | 2021 | 18 | 22 | $11,066 | $4,318 | 39.0% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 17 | 17 | $8,313 | $3,255 | 39.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $8,337 | $3,232 | 38.8% |
About Dr. Jonathan Herschman, M.D
Dr. Jonathan Herschman, M.D is a Urology healthcare provider based in Adrian, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154353076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Herschman, M.D has received a total of $3,818 in payments from pharmaceutical and medical device companies, with $187.06 received in 2024. These payments were reported across 41 transactions from 19 companies. The most common payment nature is "Education" ($3,000).
As a Medicare-enrolled provider, Herschman has provided services to 2,180 Medicare beneficiaries, totaling 2,638 services with total Medicare billing of $141,498. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Adrian, MI
- Active Since 07/07/2006
- Last Updated 11/03/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1154353076
Products in Payments
- Da Vinci Surgical System (Device) $3,000
- XTANDI (Drug) $141.01
- LUPRON DEPOT (Drug) $108.65
- KEYTRUDA (Biological) $96.26
- ORGOVYX (Drug) $55.26
- ERLEADA (Drug) $48.85
- CURE CATHETER (Device) $47.90
- MYRBETRIQ (Drug) $42.28
- NOCDURNA (Drug) $37.08
- ELIGARD (Drug) $27.79
- PYLARIFY (Drug) $22.46
- SANDOSTATIN LAR (Drug) $20.88
- Lupron (Drug) $18.73
- XYOSTED (Drug) $18.29
- RESONANCE (Device) $17.64
- SpeediCath (Device) $17.02
- MAGIC3 INTERMITTENT CATHETER (Device) $16.63
- Xofigo (Drug) $15.32
- Trinity (Device) $13.90
- Rezum Generator (Device) $13.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.